vs
Cytek Biosciences, Inc.（CTKB）与COMSCORE, INC.（SCOR）财务数据对比。点击上方公司名可切换其他公司
COMSCORE, INC.的季度营收约是Cytek Biosciences, Inc.的1.5倍（$93.5M vs $62.1M），COMSCORE, INC.净利率更高（3.2% vs -70.9%，领先74.2%），Cytek Biosciences, Inc.同比增速更快（8.1% vs -1.5%），COMSCORE, INC.自由现金流更多（$2.9M vs $-1.8M），过去两年Cytek Biosciences, Inc.的营收复合增速更高（17.7% vs 3.8%）
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
Comscore是总部设于美国的全球媒体测量与分析企业，为企业、广告代理商、品牌营销方及媒体出版方提供专业营销数据与分析服务，在全球媒体行业和营销领域拥有广泛影响力。
CTKB vs SCOR — 直观对比
营收规模更大
SCOR
是对方的1.5倍
$62.1M
营收增速更快
CTKB
高出9.7%
-1.5%
净利率更高
SCOR
高出74.2%
-70.9%
自由现金流更多
SCOR
多$4.7M
$-1.8M
两年增速更快
CTKB
近两年复合增速
3.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $62.1M | $93.5M |
| 净利润 | $-44.1M | $3.0M |
| 毛利率 | 52.9% | 41.0% |
| 营业利润率 | -9.0% | 7.0% |
| 净利率 | -70.9% | 3.2% |
| 营收同比 | 8.1% | -1.5% |
| 净利润同比 | -557.1% | -3.7% |
| 每股收益（稀释后） | — | $9.50 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTKBSCOR
| Q4 25 | $62.1M | $93.5M | ||
| Q3 25 | $52.3M | $88.9M | ||
| Q2 25 | $45.6M | $89.4M | ||
| Q1 25 | $41.5M | $85.7M | ||
| Q4 24 | $57.5M | $94.9M | ||
| Q3 24 | $51.5M | $88.5M | ||
| Q2 24 | $46.6M | $85.8M | ||
| Q1 24 | $44.9M | $86.8M |
净利润CTKBSCOR
| Q4 25 | $-44.1M | $3.0M | ||
| Q3 25 | $-5.5M | $453.0K | ||
| Q2 25 | $-5.6M | $-9.5M | ||
| Q1 25 | $-11.4M | $-4.0M | ||
| Q4 24 | $9.6M | $3.1M | ||
| Q3 24 | $941.0K | $-60.6M | ||
| Q2 24 | $-10.4M | $-1.7M | ||
| Q1 24 | $-6.2M | $-1.1M |
毛利率CTKBSCOR
| Q4 25 | 52.9% | 41.0% | ||
| Q3 25 | 52.7% | 40.6% | ||
| Q2 25 | 52.3% | 40.6% | ||
| Q1 25 | 48.6% | 39.6% | ||
| Q4 24 | 58.5% | 42.4% | ||
| Q3 24 | 56.3% | 41.2% | ||
| Q2 24 | 54.6% | 39.5% | ||
| Q1 24 | 51.3% | 42.3% |
营业利润率CTKBSCOR
| Q4 25 | -9.0% | 7.0% | ||
| Q3 25 | -17.6% | 1.9% | ||
| Q2 25 | -23.3% | -1.9% | ||
| Q1 25 | -36.1% | -2.4% | ||
| Q4 24 | 5.2% | 4.1% | ||
| Q3 24 | -8.2% | -67.4% | ||
| Q2 24 | -18.3% | -2.2% | ||
| Q1 24 | -23.9% | -2.2% |
净利率CTKBSCOR
| Q4 25 | -70.9% | 3.2% | ||
| Q3 25 | -10.5% | 0.5% | ||
| Q2 25 | -12.2% | -10.6% | ||
| Q1 25 | -27.5% | -4.7% | ||
| Q4 24 | 16.8% | 3.3% | ||
| Q3 24 | 1.8% | -68.5% | ||
| Q2 24 | -22.4% | -2.0% | ||
| Q1 24 | -13.8% | -1.2% |
每股收益（稀释后）CTKBSCOR
| Q4 25 | — | $9.50 | ||
| Q3 25 | — | $-0.86 | ||
| Q2 25 | — | $-2.73 | ||
| Q1 25 | — | $-1.66 | ||
| Q4 24 | — | $-0.47 | ||
| Q3 24 | — | $-12.79 | ||
| Q2 24 | — | $-1.19 | ||
| Q1 24 | — | $-1.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | $23.6M |
| 总债务越低越好 | — | $41.5M |
| 股东权益账面价值 | $341.7M | $111.4M |
| 总资产 | $461.5M | $407.7M |
| 负债/权益比越低杠杆越低 | — | 0.37× |
8季度趋势，按日历期对齐
现金及短期投资CTKBSCOR
| Q4 25 | $90.9M | $23.6M | ||
| Q3 25 | $93.3M | $26.7M | ||
| Q2 25 | $75.5M | $26.0M | ||
| Q1 25 | $95.3M | $31.0M | ||
| Q4 24 | $98.7M | $29.9M | ||
| Q3 24 | $162.3M | $20.0M | ||
| Q2 24 | $177.9M | $14.7M | ||
| Q1 24 | $168.8M | $18.7M |
总债务CTKBSCOR
| Q4 25 | — | $41.5M | ||
| Q3 25 | — | $41.4M | ||
| Q2 25 | — | $41.3M | ||
| Q1 25 | — | $41.3M | ||
| Q4 24 | — | $41.2M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益CTKBSCOR
| Q4 25 | $341.7M | $111.4M | ||
| Q3 25 | $378.6M | $-26.3M | ||
| Q2 25 | $377.6M | $-21.7M | ||
| Q1 25 | $379.6M | $-13.5M | ||
| Q4 24 | $395.7M | $-8.3M | ||
| Q3 24 | $385.5M | $-2.7M | ||
| Q2 24 | $389.1M | $45.8M | ||
| Q1 24 | $392.6M | $51.4M |
总资产CTKBSCOR
| Q4 25 | $461.5M | $407.7M | ||
| Q3 25 | $494.9M | $406.9M | ||
| Q2 25 | $493.3M | $415.9M | ||
| Q1 25 | $482.6M | $421.5M | ||
| Q4 24 | $499.5M | $430.2M | ||
| Q3 24 | $491.2M | $412.5M | ||
| Q2 24 | $483.7M | $474.1M | ||
| Q1 24 | $492.1M | $477.7M |
负债/权益比CTKBSCOR
| Q4 25 | — | 0.37× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-771.0K | $3.2M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | $2.9M |
| 自由现金流率自由现金流/营收 | -2.9% | 3.1% |
| 资本支出强度资本支出/营收 | 1.6% | 0.3% |
| 现金转化率经营现金流/净利润 | — | 1.07× |
| 过去12个月自由现金流最近4个季度 | $-8.8M | $21.8M |
8季度趋势，按日历期对齐
经营现金流CTKBSCOR
| Q4 25 | $-771.0K | $3.2M | ||
| Q3 25 | $-3.9M | $9.5M | ||
| Q2 25 | $108.0K | $932.0K | ||
| Q1 25 | $-125.0K | $9.1M | ||
| Q4 24 | $2.0M | $-10.0M | ||
| Q3 24 | $13.2M | $12.5M | ||
| Q2 24 | $6.2M | $8.7M | ||
| Q1 24 | $4.0M | $6.9M |
自由现金流CTKBSCOR
| Q4 25 | $-1.8M | $2.9M | ||
| Q3 25 | $-4.6M | $9.4M | ||
| Q2 25 | $-1.5M | $787.0K | ||
| Q1 25 | $-974.0K | $8.7M | ||
| Q4 24 | $1.1M | $-10.3M | ||
| Q3 24 | $12.2M | $12.4M | ||
| Q2 24 | $5.2M | $8.5M | ||
| Q1 24 | $3.4M | $6.6M |
自由现金流率CTKBSCOR
| Q4 25 | -2.9% | 3.1% | ||
| Q3 25 | -8.7% | 10.5% | ||
| Q2 25 | -3.2% | 0.9% | ||
| Q1 25 | -2.3% | 10.1% | ||
| Q4 24 | 1.9% | -10.8% | ||
| Q3 24 | 23.7% | 14.0% | ||
| Q2 24 | 11.0% | 10.0% | ||
| Q1 24 | 7.6% | 7.6% |
资本支出强度CTKBSCOR
| Q4 25 | 1.6% | 0.3% | ||
| Q3 25 | 1.3% | 0.1% | ||
| Q2 25 | 3.5% | 0.2% | ||
| Q1 25 | 2.0% | 0.4% | ||
| Q4 24 | 1.6% | 0.2% | ||
| Q3 24 | 2.0% | 0.1% | ||
| Q2 24 | 2.3% | 0.2% | ||
| Q1 24 | 1.3% | 0.3% |
现金转化率CTKBSCOR
| Q4 25 | — | 1.07× | ||
| Q3 25 | — | 20.96× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | -3.19× | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
SCOR
| Transferred Over Time | $77.1M | 83% |
| Research Insight Solutions | $14.6M | 16% |
| Related Party | $2.5M | 3% |
